Products
BioEngine has developed nearly 100 types of serum-free media for different cell lines, which are suitable for antibodies, vaccines and cell and gene therapy (CGT) fields.
Different production processes have a great influence on the quality of the medium. From the perspective of powder production, the particle size and mixing uniformity of powder is very important. If the particle size of the powder is uneven, too many coarse particles or fine particles may lead to powder stratification during storage and transportation, which will also have a certain impact when the solution is dissolved. In addition, heat may be generated during the grinding process, which may cause powder performance changes or raw material failure, so low-temperature grinding can reduce this risk.
After research and selection of many powder grinding and mixing devices, BioEngine finally adopted the Cone Mixing/Pin Milling (CMPM) powder production technology. The product has high uniformity and concentrated particle size distribution. The product is not easy to stratify during storage and transportation, and the quality is stable. In addition, CMPM enables continuous low-temperature grinding to ensure that material characteristics do not change during the production process and that the risks of production are controllable.
The phase II production base of BioEngine has completed the construction of low-temperature CMPM process consistency amplification for the 1,000-liter level, 10,000-liter level, and 100,000-liter level, which ensures the stability and reliable quality of the culture media products. At the same time, it improves the development efficiency of the customer's pilot stage process (from 8 hours to 4 hours) and the process development capability for large-scale production.
Mix well in a shorter time;
Low line speed, low shear, and virtually no heat generation.
Cryogenic grinding by gas cooling;
Concentrated particle size distribution, no stratification;
Continuous production, suitable for high-efficient mass production;
No need for screening, no screen blocking.
Uniform mixing of trace elements, with little variation between batches
Reduce human interference
High production efficiency, suitable for mass production
Reduce the risk of thermal material inactivation
Prevent the oxidation and inactivation of reducing substances
Sole source of information, standardized implementation
Annual capacity of 1300 tons (about 55 million liters) for GMP-grade powder culture media
Annual capacity of 500,000 liters for GMP-grade liquid culture media
Production line | Type | Batch capacity | Process | Grade |
---|---|---|---|---|
P0 | Powder | 1kg | Mechanical crushing | Research |
P1 | Powder | 26kg (eq. 1000 L) | CMPM | Research |
P2 | Powder | 26kg (eq. 1000 L) | Cone mixing/ air milling | Research |
P3 | Powder | 260kg (eq. 10,000 L) | CMPM | GMP |
P4 | Powder | 2600kg (eq. 100,000 L) | CMPM | GMP |
L1 | Liquid | 100L | C+A manual canning | Research |
L2 | Liquid | 1000L | B+A automatic canning | GMP |
We have a professional technical team to provide high quality one-stop cell culture service from process development
and optimization, medium formulation design to medium processing and manufacturing for all biopharmaceutical companies.
If you have any question, please click "Quick Message" and leave your message, we will reply to you as soon as possible.
If anything urgent, please call (86)21-68582660-2792.
3F&4F, Building 3, Lane 396, Lvzhou Ring Road, Minhang District, Shanghai, PRC